Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis (Crypto)

This study has been completed.
Doris Duke Charitable Foundation
University of Pennsylvania
Information provided by (Responsible Party):
Gregory Bisson, Botswana-UPenn Partnership Identifier:
First received: September 11, 2009
Last updated: February 3, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):